Semaglutide Tablets and the NHS: Understanding Your Options

Wegovy tablets (semaglutide 25mg maintenance dose) are MHRA-approved for weight loss in UK adults with BMI ≥30, or ≥27 with a weight-related condition — but are not yet available on the NHS.
The tablet requires no refrigeration and is taken once daily first thing in the morning, at least 30 minutes before food or drink, making it a genuinely travel-friendly alternative to the injection.
In the OASIS 4 phase-3 trial, participants lost an average of around 13.6% of body weight over 64 weeks; those who stayed fully adherent averaged approximately 16.6%.
Because no NHS pathway exists yet, the only legal route is a private prescription from a regulated UK prescriber, the same clinical standards apply regardless of who issues it.

Semaglutide tablets for weight loss are not currently available on the NHS. The oral formulation, branded Wegovy tablets, received MHRA approval on 11 June 2026 as the UK's first licensed oral GLP-1 medicine for weight management — but a NICE appraisal is required before NHS commissioning can follow, and none has begun. For now, access means a private prescription following clinical assessment. That reality shapes every decision covered below, and it's worth understanding clearly before you decide what to do next. These are prescription-only medicines; a qualified prescriber determines whether they are clinically appropriate for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Making sense of the private route for oral semaglutide in the UK

Why semaglutide tablets are not on the NHS right now

The MHRA granted approval for Wegovy tablets on 11 June 2026, making the UK the first country in Europe to license an oral GLP-1 medicine for weight management. That is significant. What it does not do is trigger NHS prescribing automatically. In England, a medicine joins the NHS formulary for a specific condition only after NICE issues a positive technology appraisal, and that process typically takes twelve months or more from marketing authorisation. The MHRA and NICE are separate organisations with separate remits; one decides whether a medicine is safe and effective enough to be sold in the UK, the other decides whether the NHS should fund it and for whom.

There is a common misconception that MHRA approval effectively means it is available everywhere. It does not. Wegovy injections, for instance, hold a NICE recommendation under TA875 but access through NHS specialist services still involves long waiting lists for most people. Tablets are earlier in that journey still. This is not a gap in the system so much as the system working exactly as designed, and understanding it prevents a frustrating wait for something that is not yet coming.

Scotland, Wales and Northern Ireland operate their own appraisal bodies, so timing and criteria may differ across the nations. If you are researching this from outside England, it is worth checking with your health board directly.

What the MHRA licence actually means for you as a patient

MHRA approval does matter practically. It means that a registered UK prescriber can legally issue a private prescription for Wegovy tablets today, and that a GPhC-registered pharmacy can legally dispense it. The clinical standards are identical to any other licensed medicine: a prescriber must assess you, satisfy themselves that the treatment is appropriate, and issue a formal prescription. There are no shortcuts built into the approval.

The licensed population is adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea. Lower thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone is never the whole picture; your prescriber looks at your medical history, any current medicines, and contraindications before deciding.

The dosing schedule starts at 1.5mg and moves through 4mg and 9mg to the 25mg maintenance dose, with at least a month at each level. People already established on the 2.4mg weekly injection may move directly to the 25mg tablet, subject to their prescriber's assessment. For exact administration guidance (including the 30-minute fasting window and the small sip of plain water required) the patient information leaflet is the definitive reference, as described in the NHS semaglutide medicines page.

How to access semaglutide tablets privately and what to expect

Because there is no NHS route, your decision is really about which private prescriber and pharmacy to trust. The starting point is always the GPhC register: any online pharmacy dispensing this medicine should be verifiable there. You can check our own GPhC registration (premises number 9012878) at the pharmacy register.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. If you are clinically suitable and order before noon on a weekday, treatment is dispatched the same day and arrives via tracked DPD delivery the next working day. There is no subscription and no auto-renewal; every repeat order goes through clinical review again. You can read more about how oral semaglutide works if you want a fuller picture of the medicine before deciding.

If you are curious about the cost side of things, our treatment overview explains what is included in the price. The one thing worth saying here: patients who want to buy semaglutide tablets online should know that for a prescription medicine, the cheapest option is rarely the safest test to apply. Supply chain legitimacy and clinical oversight are what actually protect you.

Wegovy tablets are not suitable during pregnancy, breastfeeding, or if you are trying to conceive. They are not licensed for under-18s. If any of those apply, your prescriber will discuss what that means for you. Questions about whether a specific medicine or existing condition changes your eligibility are best raised directly with our clinical team via our contact page or during your consultation.

What to do while an NHS pathway develops

NICE appraisals move at their own pace. If you are waiting to see whether semaglutide tablets eventually become available on the NHS, that is a completely reasonable position, and checking the NICE website for any published appraisal consultations costs nothing. For those wondering where they can buy semaglutide tablets in the UK right now, private treatment through a regulated prescriber is the legal alternative.

Our FAQs page covers some of the questions that come up most often about eligibility and the consultation process, including guidance for anyone looking to buy a semaglutide tablet for the first time. If you have already decided you want to explore this properly, the next step is a free consultation with our prescribers. There is no obligation to proceed, and you get a genuine clinical review either way. You can also learn more about who we are before you start.

When you are ready, patients can view semaglutide tablets for sale and buy semaglutide tablets by starting your free consultation, and our prescribers will take it from there.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions